Europe - Euronext Milan - BIT:1AFX - DE0005313704 - Common Stock
The current stock price of 1AFX.MI is 28.88 EUR.
ChartMill assigns a technical rating of 2 / 10 to 1AFX.MI.
ChartMill assigns a fundamental rating of 5 / 10 to 1AFX.MI. Both the profitability and the financial health of 1AFX.MI get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months 1AFX.MI reported a non-GAAP Earnings per Share(EPS) of 1.61. The EPS decreased by -19.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.34% | ||
| ROA | 4.15% | ||
| ROE | 6.67% | ||
| Debt/Equity | 0.27 |
22 analysts have analysed 1AFX.MI and the average price target is 49.99 EUR. This implies a price increase of 73.11% is expected in the next year compared to the current price of 28.88.
For the next year, analysts expect an EPS growth of 20.35% and a revenue growth 4.23% for 1AFX.MI
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
CARL ZEISS MEDITEC AG - BR
Goeschwitzer Strasse 51-52
Jena THUERINGEN DE
Employees: 5784
Phone: 493641220331
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
The current stock price of 1AFX.MI is 28.88 EUR. The price increased by 0.84% in the last trading session.
CARL ZEISS MEDITEC AG - BR (1AFX.MI) has a dividend yield of 1.87%. The yearly dividend amount is currently 0.6.
1AFX.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
22 analysts have analysed 1AFX.MI and the average price target is 49.99 EUR. This implies a price increase of 73.11% is expected in the next year compared to the current price of 28.88.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1AFX.MI.
CARL ZEISS MEDITEC AG - BR (1AFX.MI) has a market capitalization of 2.58B EUR. This makes 1AFX.MI a Mid Cap stock.